National Lab Briefs

Light Source Fortunes Brighten After five years of rejection, Argonne National Lab has finally garnered congressional approval to begin construction of its $456 million Advanced Photon Source. Wasting not a moment, the lab broke ground just days after receiving $40 million for construction in the 1990 DOE budget, which took effect October 1. The APS, which will be the nation’s second-largest basic science project (after the Superconducting Supercollider) when it is completed in 1995, is

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

After five years of rejection, Argonne National Lab has finally garnered congressional approval to begin construction of its $456 million Advanced Photon Source. Wasting not a moment, the lab broke ground just days after receiving $40 million for construction in the 1990 DOE budget, which took effect October 1. The APS, which will be the nation’s second-largest basic science project (after the Superconducting Supercollider) when it is completed in 1995, is designed to produce the brightest X-ray beams in the world. Focused X-ray radiation, with a wavelength as short as 1 angstrom, is used to observe molecular, atomic, and chemical processes with unprecedented detail. APS officials plan to operate the facility like an apartment building, “leasing” 34 experimental areas around the 3,600-foot ring. With a $500,000 initial fee, researchers will be able to reserve a sector for their own use; after that, academic and governmept scientists pay only their own ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies